Breast Biopsy Market Share, Overview, Competitive Analysis and Forecast 2031

Comments · 74 Views

The Breast Biopsy Market in 2023 is US$ 1.60 billion, and is expected to reach US$ 3.54 billion by 2031 at a CAGR of 10.40%.

The Breast Biopsy Market in 2023 is US$ 1.60 billion, and is expected to reach US$ 3.54 billion by 2031 at a CAGR of 10.40%.

FutureWise Research published a report that analyzes Breast Biopsy Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the market trends and driving factors presented in the report, clients will be able to plan the roadmap for their products and services taking into account various socio-economic factors.

Additionally, it illustrates the corporate profiles and situation of competitive landscape amongst numerous associated corporations including the analysis of market evaluation and options associated with the worth chain. This Breast Biopsy research report provides insights on market overview, market segmentation, current and future pricing, growth analysis, competitive landscape and other such premium insights within the forecast period.

 

Request a Sample Report @ Request for Breast Biopsy Market Sample

 

Breast Biopsy Market Segmentation:

By Product

·        Biopsy Needles

·        Guidance Systems

·        Biopsy Tables

·        Assay Kits

·        Liquid Biopsy Instrument

·        Localizing Wires

By Type

·        Needle Breast Biopsy

·        Core Needle Biopsy

·        Vaccum-Assisted Biopsy(VAB)

·        Fine Needle Aspiration Biopsy(FNAB)

·        Open Surgical Breast Biopsy

·        Excisional

·        Incisional

·        Liquid Breast Biopsy

·        Circulating Tumor Cell

·        Circulating Tumor DNA(CTDNA)

By Guidance

·        Image Guided Biopsy

·        Mammography-Guided Stereotactic Biopsy

·        UltraSound-Guided Biopsy

·        MRI-Guided Biopsy

·        Liquid Biopsy

·        PCR-Based Biopsy

·        NGS-Based Biopsy

·        Microarray-Based Biopsy

By Application

·        Early Cancer Screening

·        Therapy Selection

·        Treatment Monitoring

·        Recurrence Monitoring

By Region

       North America

       Europe

       Asia-Pacific

       Latin America

       Middle East and Africa

Major players included in the Breast Biopsy Market:

·        Hologic, Inc

·        Danaher Corporation

·        Argon Medical

·        Becton, Dickinson and Company

·        IZI Medical Products

·        Merit Medical Systems

·        Menarina Silicon Biosystem spa

·        Scion Medical Technologies, LLC

·        Medtronic

·        Sterylab S.R.L

·        Bioceps, Inc

·        Bio-Rad Laboratories, Inc

·        F.Hoffmann-la Roche Ltd

·        Qiagen

·        Exact Sciences Corporation

·        Thermo Fisher Scientific

·        Cardiff Oncology, Inc.

·        Myriad Genetics, Inc.

·        Illumina, Inc.

·        Fluxion Biosciences, Inc

 

Please visit full report of the Breast Biopsy market @ Visit Breast Biopsy Market

Competitive Landscape:

·         Tier one players - market players with a significant share of the market

·         Tier two players

·         Players with rapid growth

·         New Entries

 

FutureWise Key Takeaways:

      

Comments